NEXSCIENT INC (NXNT) Financials
Newest figures come from the 10-Q for Q4 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the NXNT SEC filings page.
NEXSCIENT INC (NXNT) reported $1.1M in revenue over the twelve months to Jun 30, 2026. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 2 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Reported losses were financed externally while liabilities overtook assets, leaving a balance sheet with negative equity.
In FY2025, the company recorded a net loss of$530K and operating cash outflow of$408K , so accounting losses broadly translated into cash consumption rather than merely reflecting non-cash charges. Financing inflows of$480K were larger than that operating outflow, indicating reported funding—not internally generated cash—bridged the period.
Liabilities exceeded assets in FY2025—
Some figures from recent filings were inconsistent and were omitted from this summary.
Financial Health Signals
NEXSCIENT INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
NEXSCIENT INC passes 1 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 3 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), the one computable operating efficiency signal (asset turnover improving) does not pass.
NEXSCIENT INC reported a net loss of $530K while operations used $408K of cash. With neither figure positive, the ratio between the two carries no quality signal.
NEXSCIENT INC reported an operating loss of $488K against $42K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
NEXSCIENT INC generated $1.1M in revenue in Q4 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
NEXSCIENT INC's EBITDA was -$372K in Q4 2026, measuring earnings before interest, taxes, depreciation, and amortization.
NEXSCIENT INC reported a net loss of $430K in Q4 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Cash & Balance Sheet
NEXSCIENT INC held $489K in cash against $297K in long-term debt as of Q4 2026.
Not reported for Q4 2026.
Not reported for Q4 2026.
Margins & Returns
NEXSCIENT INC's gross margin was 39.4% in Q4 2026, indicating the percentage of revenue retained after direct costs.
NEXSCIENT INC's operating margin was -34.2% in Q4 2026, reflecting core business profitability.
NEXSCIENT INC's net profit margin was -38.8% in Q4 2026, showing the share of revenue converted to profit.
NEXSCIENT INC's quarterly ROE was -20.1% in Q4 2026: one quarter's net income over shareholder equity, not annualized. Against the prior quarter it is up 80.4 percentage points.
Capital Allocation
NEXSCIENT INC invested $23K in research and development in Q4 2026. This represents an increase of 119.0% from the same quarter a year earlier. Against the prior quarter it is up 228.6%.
Not reported for Q4 2026.
Not reported for Q4 2026.
NXNT Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.1Mn/m | $0n/m | $0n/m | $0n/m | $0 | $0n/m | $0n/m | $0n/m |
| Cost of Revenue | $673Kn/m | N/A | N/A | N/A | $0 | N/A | N/A | N/A |
| Gross Profit | $437Kn/m | N/A | N/A | N/A | $0 | N/A | N/A | N/A |
| R&D Expenses | $23K+119.0% | $7Kn/m | $11K+5.0% | $11K-85.0% | $11K | $0-100.0% | $10K-80.1% | $70K+365.8% |
| SG&A Expenses | $659K+645.8% | $108K+0.3% | $127K-15.2% | $144K+150.0% | $88K | $108K-31.7% | $150K-9.7% | $58K-74.7% |
| Operating Income | -$380Kn/m | N/A | N/A | N/A | -$99K | N/A | N/A | N/A |
| EBITDA | -$372K | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | $20K+138.6% | $12K+81.3% | $12Kn/m | $12Kn/m | $9K | $6K | $0 | $0 |
| Income Tax | -$2Kn/m | N/A | N/A | N/A | $0 | N/A | N/A | N/A |
| Net Income | -$430Kn/m | -$127Kn/m | -$149Kn/m | -$167Kn/m | -$107K | -$135Kn/m | -$160Kn/m | -$128Kn/m |
| EPS (Diluted) | -$0.01 | -$0.01n/m | N/A | N/A | -$0.01 | -$0.01 | -$0.01n/m | N/A |
| Diluted Shares (Avg) | 33M | 22M+8.1% | N/A | N/A | 21M | 21M | 20M+2.3% | N/A |
Not reported in any period shown, so not listed: EPS (Basic).
NXNT Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.7M+1451.6% | $976K+439.5% | $288K+203.7% | $235K+28.2% | $302K+142.5% | $181K-22.2% | $95K-61.1% | $184K-57.9% |
| Current Assets | $1.3M+705.3% | $808K+2222.6% | $115K+45.6% | $99K-39.5% | $160K+60.6% | $35K-85.0% | $79K-67.5% | $163K-62.5% |
| Cash & Equivalents | $489K+386.9% | $755K+3432.0% | $28K-64.0% | $59K-61.1% | $100K+32.5% | $21K-87.4% | $79K-67.5% | $151K-65.3% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Accounts Receivable | $493K | N/A | $0 | N/A | N/A | N/A | N/A | N/A |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Goodwill | $2.6M | N/A | $0 | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $2.5M+348.0% | $849K+113.9% | $784K+161.0% | $667K+190.7% | $566K+1229.9% | $397K+2638.0% | $300K+1989.3% | $229K+2492.7% |
| Current Liabilities | $1.8M+2636.4% | $622K+1082.8% | $486K+1677.9% | $104K+116.7% | $65K+79.2% | $53K+262.6% | $27K+90.0% | $48K+440.4% |
| Non-Current Liabilities | $762K+51.9% | $227K-34.0% | $298K+9.2% | $563K+210.2% | $501K+7763.7% | $344Kn/m | $273Kn/m | $182Kn/m |
| Long-Term Debt | $297K-38.2% | $200K | $265K0.0% | $530K | $480Kn/m | N/A | $265K | N/A |
| Total Equity | $2.1Mn/m | $127Kn/m | -$496Kn/m | -$432Kn/m | -$265K-423.5% | -$216K-199.2% | -$206K-189.9% | -$46K-110.7% |
| Retained Earnings | -$2.4Mn/m | -$2.0Mn/m | -$1.9Mn/m | -$1.7Mn/m | -$1.6Mn/m | -$1.5Mn/m | -$1.3Mn/m | -$1.2Mn/m |
Not reported in any period shown, so not listed: Inventory.
NXNT Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | N/A | -$23Kn/m | -$40Kn/m | -$92Kn/m | -$41Kn/m | -$105Kn/m | -$157Kn/m | -$104Kn/m |
| Depreciation & Amortization | $8K | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | $0n/m | N/A | N/A | $0n/m | -$48K | N/A | N/A |
| Financing Cash Flow | N/A | $750K+689.5% | $10K-88.2% | $50K-72.2% | $120K+140.0% | $95K-9.1% | $85K+385.7% | $180K-48.1% |
Not reported in any period shown, so not listed: Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
NXNT Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 39.4% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | -34.2% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | -38.8% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | -20.1% | -100.4% | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -9.2%+26.4pp | -13.0%+61.5pp | -52.0%+116.8pp | -70.9%-1.4pp | -35.6% | -74.6%+18.9pp | -168.8%-79.9pp | -69.5%-13.8pp |
| Current Ratio | 0.73-1.7x | 1.30+0.6x | 0.24-2.7x | 0.95-2.5x | 2.47-0.3x | 0.66-15.4x | 2.89-14.0x | 3.42-45.9x |
| Debt-to-Equity | 0.14 | 1.58 | N/A | N/A | N/A | N/A | N/A | N/A |
| Liabilities-to-Equity | 1.18 | 6.70 | N/A | N/A | N/A | N/A | N/A | N/A |
| Asset Turnover | 0.24+0.2x | 0.000.0x | 0.000.0x | 0.000.0x | 0.00 | 0.000.0x | 0.000.0x | 0.000.0x |
Not reported in any period shown, so not listed: FCF Margin.
Note: Shareholder equity is negative (-$265K), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Where NEXSCIENT INC Ranks
Frequently Asked Questions
What is NEXSCIENT INC's annual revenue?
NEXSCIENT INC (NXNT) reported $0 in total revenue for fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Is NEXSCIENT INC profitable?
No, NEXSCIENT INC (NXNT) reported a net loss of $874K over the trailing 12 months to June 30, 2026. In fiscal year 2025 it reported a net loss of $530K.
What is NEXSCIENT INC's EBITDA?
NEXSCIENT INC (NXNT) had EBITDA of -$468K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does NEXSCIENT INC have?
As of fiscal year 2025, NEXSCIENT INC (NXNT) had $100K in cash and equivalents against $480K in long-term debt.
What is NEXSCIENT INC's operating cash flow?
NEXSCIENT INC (NXNT) recorded an outflow of $408K in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are NEXSCIENT INC's total assets?
NEXSCIENT INC (NXNT) had $302K in total assets as of fiscal year 2025, including both current and long-term assets.
How much does NEXSCIENT INC spend on research and development?
NEXSCIENT INC (NXNT) invested $97K in research and development during fiscal year 2025.
What is NEXSCIENT INC's current ratio?
NEXSCIENT INC (NXNT) had a current ratio of 2.47 as of fiscal year 2025, which is generally considered healthy.
What is NEXSCIENT INC's return on assets (ROA)?
NEXSCIENT INC (NXNT) had a return on assets of -175.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Why is NEXSCIENT INC's debt-to-equity ratio negative or not reported?
NEXSCIENT INC (NXNT) has negative shareholder equity of -$265K as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is NEXSCIENT INC's Piotroski F-Score?
NEXSCIENT INC (NXNT) has a Piotroski F-Score of 1 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are NEXSCIENT INC's earnings high quality?
NEXSCIENT INC (NXNT) reported a net loss of $530K while operations used $408K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can NEXSCIENT INC cover its interest payments?
NEXSCIENT INC (NXNT) reported an operating loss of $488K against $42K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.